This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim Pharmaceuticals, Inc.. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: John Landi: Innovator in Asymmetric Synthesis
Introduction
John Landi is an accomplished inventor based in Gardner, MA (US). He has made significant contributions to the field of chemistry, particularly in the area of asymmetric synthesis. His work has led to advancements that are valuable in various applications, including pharmaceuticals.
Latest Patents
John Landi holds a patent for the invention titled "Asymmetric synthesis of .alpha.-cycloalkylalkyl substituted methanamines." This invention relates to a process for asymmetrically producing enantiomerically pure .alpha.-cycloalkylalkyl substituted methanamines from .alpha.-pinene. A key step in this process utilizes the oxidation product of .alpha.-pinene, hydroxy pinanone, as a chiral auxiliary to direct the stereoselective alkylation of the corresponding ketimine. This invention also encompasses key intermediates that are useful in the processes described.
Career Highlights
John Landi is currently employed at Boehringer Ingelheim Pharmaceuticals, Inc., where he continues to apply his expertise in chemistry and innovation. His work at this prominent pharmaceutical company allows him to contribute to the development of new and effective medications.
Collaborations
John collaborates with Gregory Paul Roth, a fellow professional in the field. Their partnership enhances the research and development efforts at Boehringer Ingelheim Pharmaceuticals, Inc.
Conclusion
John Landi's contributions to asymmetric synthesis and his innovative patent demonstrate his commitment to advancing the field of chemistry. His work not only showcases his expertise but also highlights the importance of collaboration in driving scientific progress.